share_log

华润双鹤:通过药品GMP符合性检查

China Resources Double-Crane Pharmaceutical: Passed the Pharmaceutical GMP compliance inspection.

Breakings ·  Dec 17 17:01

China Resources Double-Crane Pharmaceutical announced that it recently received the "Pharmaceutical GMP Compliance Inspection Notice" issued by the Peking Municipal Drug Administration. The scope of the inspection covers the freeze-drying workshop small-volume injectable S production line, with a designed capacity of 7 million vials per year, producing Sugammadex injection.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment